Related Experiment Video
Updated: Mar 27, 2026

Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation
Published on: July 15, 2015
Clinical impact of bacterial contamination of perfusion fluid in kidney transplantation
A Ranghino1, D Diena1, F Simonato1
1Renal Transplantation Center "A. Vercellone", Division of Nephrology Dialysis and Transplantation, Department of Medical Sciences, Città della Salute e della Scienza Hospital and University of Torino, Corso Dogliotti 14, 10126 Turin, Italy.
Abstract:
Contamination of perfusion fluid (PF) could lead to serious infections in kidney transplant recipients. Preemptive therapy (PE-T) in case of yeast contamination of PF is mandatory. The usefulness of PE-T in presence of bacteria remains unclear. In this study we evaluated the incidence of PF bacterial contamination and the impact of PE-T on clinical outcome. Microbiological data of 290 PF and clinical data of the corresponding recipients collected in our hospital from January 2010 and December 2012 were analyzed. Recipients with bacterial contaminated PF (101) were divided in 3 groups: group 1 (n = 52) PE-T treated bacteria resistant to perioperative antibiotic prophylaxis (PAP), group 2 (n = 28) bacteria sensitive to PAP, group 3 (n = 21) PE-T-untreated bacteria resistant to PAP. Incidence of positive PF was 34.8 %, 50.4 % staphylococci, 9.9 % C. albicans. No significant differences in the rate of PF-related infections between the three groups were found. In conclusion, although PF contamination is frequent, the incidence of PF-related infections is very low. In addition, in this study PE-T did not help to reduce the rate of PF-related infection suggesting that a resonable reduction in the use of antibiotic terapy could be made. However, waiting for largest and prospective clinical trials to confirm our findings, a closely clinical and microbiologic monitoring of the recipient is highly recommended in case of PF contamination.
Insights
Perfusion fluid contamination is common in kidney transplant recipients, but infections are rare. Preemptive therapy for bacterial contamination did not reduce infection rates, suggesting a potential for reduced antibiotic use.
Area of Science:
- Nephrology
- Transplantation Immunology
- Clinical Microbiology
Background:
- Perfusion fluid (PF) contamination poses a risk of serious infections in kidney transplant recipients.
- Preemptive therapy (PE-T) is standard for yeast PF contamination, but its efficacy for bacterial contamination is uncertain.
Purpose of the Study:
- To investigate the incidence of bacterial contamination in perfusion fluid (PF).
- To evaluate the impact of preemptive therapy (PE-T) on clinical outcomes in kidney transplant recipients with bacterial PF contamination.
Main Methods:
- Retrospective analysis of microbiological data from 290 perfusion fluids (PF) and clinical data from corresponding kidney transplant recipients (January 2010 - December 2012).
- Recipients with bacterial PF contamination (n=101) were categorized into three groups: PE-T treated (resistant/sensitive to perioperative antibiotic prophylaxis - PAP) and PE-T untreated (resistant to PAP).
Main Results:
- The incidence of positive PF was 34.8%, with staphylococci (50.4%) and Candida albicans (9.9%) being the most common contaminants.
- No significant differences in PF-related infection rates were observed among the three treatment groups.
Conclusions:
- Despite frequent PF contamination, the incidence of PF-related infections in kidney transplant recipients is low.
- Preemptive therapy (PE-T) for bacterial PF contamination did not demonstrate a reduction in infection rates in this study.
- Findings suggest a potential for reducing antibiotic therapy, pending confirmation from larger prospective trials. Close clinical and microbiological monitoring is recommended for recipients with PF contamination.
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Acute Kidney Injury V: Interprofessional Care

